Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin

Sarah D. Brown, Paola Nativo, Jo-Ann Smith, David Stirling, Paul R. Edwards, Balaji Venugopal, David J. Flint, Jane A. Plumb, Duncan Graham, Nial J. Wheate

Research output: Contribution to journalArticle

482 Citations (Scopus)

Abstract

The platinum-based anticancer drugs cisplatin, carboplatin, and oxaliplatin are an important component of chemotherapy but are limited by severe dose-limiting side effects and the ability of tumors to develop resistance rapidly. These drugs can be improved through the use of drug-delivery vehicles that are able to target cancers passively or actively. In this study, we have tethered the active component of the anticancer drug oxaliplatin to a gold nanoparticle for improved drug delivery. Naked gold nanoparticles were functionalized with a thiolated poly(ethylene glycol) (PEG) monolayer capped with a carboxylate group. [Pt(1R,2R-diaminocyclohexane)(H2O)2]2NO3 was added to the PEG surface to yield a supramolecular complex with 280 (±20) drug molecules per nanoparticle. The platinum-tethered nanoparticles were examined for cytotoxicity, drug uptake, and localization in the A549 lung epithelial cancer cell line and the colon cancer cell lines HCT116, HCT15, HT29, and RKO. The platinum-tethered nanoparticles demonstrated as good as, or significantly better, cytotoxicity than oxaliplatin alone in all of the cell lines and an unusual ability to penetrate the nucleus in the lung cancer cells.
LanguageEnglish
Pages4678-4684
Number of pages7
JournalJournal of the American Chemical Society
Volume132
Issue number13
Early online date12 Mar 2010
DOIs
Publication statusPublished - 7 Apr 2010

Fingerprint

oxaliplatin
Drug delivery
Gold
Nanoparticles
Platinum
Cells
Polyethylene glycols
Pharmaceutical Preparations
Cytotoxicity
Cell Line
Lung Neoplasms
Chemotherapy
Carboplatin
Cisplatin
Tumors
Monolayers
Ethylene Glycol
Colonic Neoplasms

Keywords

  • cancer therapy
  • complexes
  • cells
  • cytotoxicity
  • chemotherapy
  • conjugate
  • stability
  • vectors
  • system
  • folate

Cite this

Brown, Sarah D. ; Nativo, Paola ; Smith, Jo-Ann ; Stirling, David ; Edwards, Paul R. ; Venugopal, Balaji ; Flint, David J. ; Plumb, Jane A. ; Graham, Duncan ; Wheate, Nial J. / Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. In: Journal of the American Chemical Society. 2010 ; Vol. 132, No. 13. pp. 4678-4684.
@article{49180b8e776a4e2da0f0c18e62971506,
title = "Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin",
abstract = "The platinum-based anticancer drugs cisplatin, carboplatin, and oxaliplatin are an important component of chemotherapy but are limited by severe dose-limiting side effects and the ability of tumors to develop resistance rapidly. These drugs can be improved through the use of drug-delivery vehicles that are able to target cancers passively or actively. In this study, we have tethered the active component of the anticancer drug oxaliplatin to a gold nanoparticle for improved drug delivery. Naked gold nanoparticles were functionalized with a thiolated poly(ethylene glycol) (PEG) monolayer capped with a carboxylate group. [Pt(1R,2R-diaminocyclohexane)(H2O)2]2NO3 was added to the PEG surface to yield a supramolecular complex with 280 (±20) drug molecules per nanoparticle. The platinum-tethered nanoparticles were examined for cytotoxicity, drug uptake, and localization in the A549 lung epithelial cancer cell line and the colon cancer cell lines HCT116, HCT15, HT29, and RKO. The platinum-tethered nanoparticles demonstrated as good as, or significantly better, cytotoxicity than oxaliplatin alone in all of the cell lines and an unusual ability to penetrate the nucleus in the lung cancer cells.",
keywords = "cancer therapy, complexes, cells, cytotoxicity, chemotherapy, conjugate, stability, vectors, system, folate",
author = "Brown, {Sarah D.} and Paola Nativo and Jo-Ann Smith and David Stirling and Edwards, {Paul R.} and Balaji Venugopal and Flint, {David J.} and Plumb, {Jane A.} and Duncan Graham and Wheate, {Nial J.}",
year = "2010",
month = "4",
day = "7",
doi = "10.1021/ja908117a",
language = "English",
volume = "132",
pages = "4678--4684",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "13",

}

Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. / Brown, Sarah D.; Nativo, Paola; Smith, Jo-Ann; Stirling, David; Edwards, Paul R.; Venugopal, Balaji; Flint, David J.; Plumb, Jane A.; Graham, Duncan; Wheate, Nial J.

In: Journal of the American Chemical Society, Vol. 132, No. 13, 07.04.2010, p. 4678-4684.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin

AU - Brown, Sarah D.

AU - Nativo, Paola

AU - Smith, Jo-Ann

AU - Stirling, David

AU - Edwards, Paul R.

AU - Venugopal, Balaji

AU - Flint, David J.

AU - Plumb, Jane A.

AU - Graham, Duncan

AU - Wheate, Nial J.

PY - 2010/4/7

Y1 - 2010/4/7

N2 - The platinum-based anticancer drugs cisplatin, carboplatin, and oxaliplatin are an important component of chemotherapy but are limited by severe dose-limiting side effects and the ability of tumors to develop resistance rapidly. These drugs can be improved through the use of drug-delivery vehicles that are able to target cancers passively or actively. In this study, we have tethered the active component of the anticancer drug oxaliplatin to a gold nanoparticle for improved drug delivery. Naked gold nanoparticles were functionalized with a thiolated poly(ethylene glycol) (PEG) monolayer capped with a carboxylate group. [Pt(1R,2R-diaminocyclohexane)(H2O)2]2NO3 was added to the PEG surface to yield a supramolecular complex with 280 (±20) drug molecules per nanoparticle. The platinum-tethered nanoparticles were examined for cytotoxicity, drug uptake, and localization in the A549 lung epithelial cancer cell line and the colon cancer cell lines HCT116, HCT15, HT29, and RKO. The platinum-tethered nanoparticles demonstrated as good as, or significantly better, cytotoxicity than oxaliplatin alone in all of the cell lines and an unusual ability to penetrate the nucleus in the lung cancer cells.

AB - The platinum-based anticancer drugs cisplatin, carboplatin, and oxaliplatin are an important component of chemotherapy but are limited by severe dose-limiting side effects and the ability of tumors to develop resistance rapidly. These drugs can be improved through the use of drug-delivery vehicles that are able to target cancers passively or actively. In this study, we have tethered the active component of the anticancer drug oxaliplatin to a gold nanoparticle for improved drug delivery. Naked gold nanoparticles were functionalized with a thiolated poly(ethylene glycol) (PEG) monolayer capped with a carboxylate group. [Pt(1R,2R-diaminocyclohexane)(H2O)2]2NO3 was added to the PEG surface to yield a supramolecular complex with 280 (±20) drug molecules per nanoparticle. The platinum-tethered nanoparticles were examined for cytotoxicity, drug uptake, and localization in the A549 lung epithelial cancer cell line and the colon cancer cell lines HCT116, HCT15, HT29, and RKO. The platinum-tethered nanoparticles demonstrated as good as, or significantly better, cytotoxicity than oxaliplatin alone in all of the cell lines and an unusual ability to penetrate the nucleus in the lung cancer cells.

KW - cancer therapy

KW - complexes

KW - cells

KW - cytotoxicity

KW - chemotherapy

KW - conjugate

KW - stability

KW - vectors

KW - system

KW - folate

U2 - 10.1021/ja908117a

DO - 10.1021/ja908117a

M3 - Article

VL - 132

SP - 4678

EP - 4684

JO - Journal of the American Chemical Society

T2 - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 13

ER -